Rion

[On Demand]
Search General Info
Search Education
Search Partnering Companies

Rion is a clinical-stage regenerative medicine company focused on developing innovative exosome therapeutics that are clinically impactful and broadly accessible. Rion has developed Purified Exosome ProductTM (PEPTM), an innovative biologic platform that harnesses the therapeutic power of exosomes for regenerative medicine. PEP is the world’s first clinical-grade room temperature stable, off-the-shelf regenerative medicine with the potential to drive tissue healing in conditions affecting millions of patients globally. Rion has active clinical and preclinical programs in wound healing, acute myocardial infarction, and women’s health applications.

Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Minnesota
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
Purified Exosome Product (PEP)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
4
Speaker
photo
CEO
Rion